Floatz logo

Sonovue

Neonatal Stroke

Turku University HospitalPhase 3Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Neonatal Stroke cohort.

Asset / SponsorPhaseRating
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
University of California, San Francisco
Phase 4BB
PREDNISONE TABLETS
University of California, San Francisco
Phase 4BB
Darbepoetin Alfa
UMC Utrecht
Phase 2CCC
AUTOLOGOUS UMBILICAL CORD BLOOD
James Baumgartner, MD
Phase 1/2CC
Autologous Human Cord Blood Derived Stem Cell
Aryn Knight
Phase 1CC

Same molecule, other indications

Sonovue is also rated in:

renal cell carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
stroke disorderDormant
B
Indicative ·
62 / 100
View asset →
carotid stenosisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →